Marietta Paraskevaides, Analyst at Lightning Health discusses the EU Joint Clinical Assessment’s impact on rare diseases and practical steps for health technology developers in the EU market
Sami Agush, Principal Consultant at Lightning Health presents research at World EPA 2026 that provides quantitative modelling evidence and a structured policy‑architecture analysis, deepening understanding of how MFN pricing could impact global health equity
Nick Stringfellow, Consultant at Lightning Health, explores key considerations for manufacturers and future lessons as the first JCAs are published.
Adam Ben Taieb, Senior Consultant at Lightning Health, explores how turning innovation into access requires more than science
Amina Igenbek, Analyst at Lightning Health presents research at ISPOR Europe 2025 on access to unregistered medicines in ten low- and middle-income countries.
Marietta Paraskevaidou, Analyst at Lightning Health presents research at ISPOR Europe 2025 exploring HTA representatives’ perspectives on patient involvement in EU-level health technology assessments.
Ethan Shum presents recent research at ISPOR EU 2025 exploring how six HTA bodies address carer quality of life (QoL)
Abigail Williams-Adewole, Analyst at Lightning Health presents research at ISPOR Europe 2024 that explores the key challenges and opportunities for the evaluation of DMTs for the treatment of Alzheimer’s disease across a range of HTA authorities, and requirements to support reimbursed patient access.
Nick Stringfellow, Senior Analyst at Lightning Health reviews the current state of medicine shortages in Europe that are disproportionately affecting generic medicines
60 seconds with Ipek Yildir, Analyst
Bhakti Dhingra, Senior Analyst at Lightning Health presents research at ISPOR Europe 2023 that explores the impact of four UK policies on evaluation of ATMPs in the UK
Nick Stringfellow, Senior Analyst at Lightning Health presents research at ISPOR Europe 2023 exploring HTA representative and payer perceptions of the proposed EU Pharmaceutical Legislation
To ensure faster access for patients we must learn the changes in stakeholders needs
Nicholas Stringfellow, Analyst at Lightning Health takes a look at the latest deliverable from EUnetHTA
60 seconds with Nick Stringfellow, Analyst
60 seconds with Bhakti Dhingra, Analyst
Your round up from this years’ ISPOR Europe
60 seconds with Doris De Causmaecker, Analyst
Tackling the rising problem of antimicrobial resistance
Maddy Dawson and Nancy Cross, Consultants at Lightning Health present research at ISPOR Europe 2022 exploring the value of technology to deduce barriers to clinical trial diversity and facilitate the development of patient-centric medicine
Jake James, Senior Analyst at Lightning Health presents research at ISPOR Europe 2022 exploring the impact the EU-JCA will have throughout European healthcare systems (HTA93)
A well deserved congratulations to Maddy, Nancy and Jake!
Doris De Causmaecker reports on this significant news
Yasmina Zegaoui writes about the affect, if implemented, the PLFSS will have on the price of medicines and the impact on manufacturers
Our expert team will be at the meeting to present their recent research
In this fact file, Nancy Cross, Senior Analyst takes a look at the healthcare system in England: a universal public healthcare system
Jake James, Analyst, investigates this further
Jake James looks at the government’s plans to shape the healthcare landscape in the coming years
Tackling the rising problem of antimicrobial resistance
Nancy Cross, Senior Analyst at Lightning Health reviews the current R&D pipeline for psychedelic drugs
In this fact file, Nasos Kipentzogolou, Senior Analyst at Lightning Health, takes a look at the healthcare system in Canada: a decentralised healthcare system
Nancy Cross, Senior Analyst at Lightning Health, provides a brief background on psychedelics and their use in medicine and clinical research
Xin Zhao, Senior Consultant at Lightning Health, maps out the impact these potential new regulations could have
Maddy Dawson, Analyst at Lightning Health shares an overview of the planned reform
Research suggests that most ICSs are yet to appoint a procurement lead and their expected structure to govern procurement is still a work in progress
Jake James, Analyst, takes a look at the recent proposal by the TLV
This years theme is loneliness
Eleanor Butler, Senior Consultant takes a closer look at this recent development
In this fact file, Maddy Dawson, Senior Analyst at Lightning Health, takes a look at the healthcare system in Germany: a dual public-private healthcare system
The EU JCA regulation will apply from 2025 onwards
Investing in our planet
Maddy Dawson, Senior Analyst and Yasmina Zegaoui, Senior Consultant, summarise the key changes that will affect the assessment and pricing of medicines in Germany and the impact these changes will have on the pharmaceutical industry
Yasmina Zegaoui, Senior Consultant at Lightning Health outlines the key changes
60 seconds with Xin Zhao, Senior Consultant
A well deserved congratulations to Eleanor and Maddy!
60 seconds with Ciaran Gallagher, Analyst
Jake James and Eleanor Butler take a look at the key highlights
Maddy Dawson, Analyst at Lightning Health, takes a look at how the draft measures, if implemented, will affect the pharmaceutical industry
European HTA – Key areas for implementation to ensure success in the new EU joint clinical assessments
60 seconds with Alan Hutton, Head of Client Engagement and Commercial Development
International Women’s Day 2022
In this fact file, Jake James, Analyst at Lightning Health, takes a look at the healthcare system in Australia: a hybrid model that supports cost-effectiveness and cost-minimisation
The updated guidance will come into effect from 1 February 2022 for new evaluations
Maddy Dawson, Analyst and Eleanor Butler, Consultant at Lightning Health provide a round up of the key topics discussed during the Supporting Pharmaceutical Innovation in Europe webinar
60 seconds with Jake James, Analyst
The first in a series of fact files reviewing global healthcare systems, Eleanor Butler, Consultant at Lightning Health takes a look at Poland
60 seconds with Stefania Zaccari, Director of Stakeholder Engagement
The expansion demonstrates Lightning Health’s continued commitment to the life sciences sector
A return to the ‘new normal’ – innovations and policies that shaped this year
Nancy Cross, Senior Analyst at Lightning Health presents a research poster at ISPOR Europe 2021 on payer awareness and perceptions of decentralised clinical trials. (POSB278)
Nasos Kipentzoglou presents new research at ISPOR Europe 2021 looking at the current processes for the evaluation of digital therapeutics (DTx), to ensure they meet the requirements of healthcare systems and ultimately, benefit patients. (POSB295)
Yasmina Zegaoui and Eleanor Butler present recent research at ISPOR Europe reviewing cross-country collaboration models with a focus on health technology assessment
Details have emerged regarding the new government’s cost-containment plans for the pharmaceutical budget
Lightning Health is proud to support World Antimicrobial Awareness Week
Our expert team will present three posters of their recent work and thinking
An overview of the recent European policy updates and the implications they may have for the launch of ATMPs in Europe
Yasmina Zegaoui, Consultant at Lightning Health, looks at how this managed entry agreement initiative can enable the reimbursement of a much-needed therapy for patients
A well deserved congratulations to Nancy and Nasos!
Yasmina Zegaoui, Senior Consultant and Nasos Kipentzoglou, Senior Analyst at Lightning Health report on some of the key topics from the two-day event
If you want to join our growing team based in the London office, get in touch!
Our expert team will be presenting three posters of our recent work and thinking
Lightning Health’s thought-leadership perspective on sustainable solutions to drive global patient access for ATMPs
60 seconds with Maddy Dawson, Analyst
60 seconds with Yasmina Zegaoui, Senior Consultant
Joshua Beddow, Junior Analyst at Lightning Health takes a look at the early market access for remdesivir in Europe
Lightning Health Ltd. today announced the change of the company name to Lightning Health Ltd
Eleanor Butler, Consultant at Lightning Health reviews the use of synthetic data and virtual cohorts to mitigate challenges associated with developing evidence in rare and complex diseases
In the last of our series of posts analysing the new access routes developed in the UK, Nasos Kipentzoglou, Analyst at Lightning Health takes an in-depth look at the international routes; the Access Consortium and Project Orbis
In the penultimate of our series of posts analysing the new access routes developed in the UK, Nasos Kipentzoglou, Analyst at Lightning Health takes a deeper dive into the Unfettered Access Procedure for marketing authorisations approved in Northern Ireland
Following the launch of Cancard in the UK, Nancy Cross, Analyst at Lightning Health talks about the positive impact the launch may have on individuals carrying medicinal cannabis
In the fourth of our series of posts analysing the new access routes developed in the UK, Nasos Kipentzoglou, Analyst at Lightning Health takes a deeper dive into the Decentralised and Mutual Recognition Reliance Procedure
In the third of our series of posts analysing the new access routes developed in the UK, Nasos Kipentzoglou, Analyst at Lightning Health looks at the European Commission Decision reliance procedure
Nancy Cross, Analyst at Lightning Health takes a look at the power of the patient perspective and its importance in increasing the understanding of the potential benefits of medical cannabis
In the second of our series of posts analysing the new access routes developed in the UK, Nasos Kipentzoglou, Analyst at Lightning Health takes a deeper dive into the rolling review procedure
How Lightning Health can support you to navigate your access challenges associated with ATMPs
In the first of a series of articles looking at the mechanisms to obtain marketing authorisation in the UK, Nasos Kipentzoglou, Analyst at Lightning Health takes an in-depth look at the 150-day National Procedure and the possible implications for manufacturers
In this article, our colleagues Eleanor Butler and Nancy Cross carry out a retrospective review of the NICE CAR-T therapy single technology appraisals
In the intro of a series of articles, Nasos Kipentzoglou, Analyst at Lightning Health provides a round up of the current mechanisms to obtain marketing authorisation in the UK
Nasos Kipentzoglou, Analyst and Eleanor Butler, Consultant at Lightning Health review the recent approach that the G-BA has taken in requiring the mandatory collection of real world evidence for Zolgensma®
Following NICE draft guidance rejecting Zynteglo, Eleanor Butler, Consultant at Lightning Health explores why the beta thalassaemia treatment is not recommend for routine NHS funding
Nancy Cross, Analyst, and Eleanor Butler, Consultant at Lightning Health review the recently published framework and discuss what this means for stakeholders
60 seconds with Nancy Cross, Analyst
The team at Lightning Health would like to…
60 seconds with Nasos Kipentzoglou, Analyst
Lightning Health attended the virtual ISPOR Europe 2020, here is our round up of the meeting.
60 seconds with Joshua Beddow, Junior Analyst
60 seconds with Alice Best, Platform and Operations Manager
60 seconds with Eleanor Butler, Consultant
This week our colleagues Eleanor Butler and Marina Kousta attended an ISPOR webinar, read their blog.
60 seconds with Marina Kousta, Analyst
60 seconds with Stuart Hurst, Executive Advisor (Launch Excellence)
60 seconds with Andrew Satherley, Joint Managing Director
60 seconds with James Whitehouse, Joint Managing Director
The Lightning Health team is delighted to announce Dr Frances Macdonald is joining the network as an executive advisor for European HTA.
NHS England has published its long-awaited long-term NHS plan, setting out the strategic objectives for the NHS over the next 10 years.
